fda_approval · anda · info

ACTAVIS ELIZABETH — ANDA approval: GABAPENTIN (unspecified)

Event date
2026-06-23 00:00:00Z
Observed
2026-07-09 22:53:28Z
Source ID
ANDA203611-1
Payload hash
21940f78d4b5b294c9f96964

Summary

ACTAVIS ELIZABETH received ANDA approval for GABAPENTIN (unspecified) on 2026-06-23. Dosage form: TABLET. Application #: ANDA203611.

Informational only. Not legal, financial, or medical advice.